Published in Indian J Ophthalmol on October 01, 2014
OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab (2002) 1.65
OPA1-associated disorders: phenotypes and pathophysiology. Int J Biochem Cell Biol (2009) 1.40
Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol (1993) 1.38
Dominant optic atrophy. The clinical profile. Arch Ophthalmol (1979) 1.34
Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1) Arch Ophthalmol (1997) 1.32
Molecular genetic basis of primary inherited optic neuropathies. Eye (Lond) (2004) 1.08
Asteroid hyalosis in an autopsy population: The University of California at Los Angeles (UCLA) experience. Arch Ophthalmol (2005) 1.30
SRPK1: a cisplatin sensitive protein expressed in retinoblastoma. Pediatr Blood Cancer (2008) 0.94
A clinical update and radiologic review of pediatric orbital and ocular tumors. J Oncol (2013) 0.89
Hypocellular scar formation or aberrant fibrosis induced by an intrastromal corneal ring: a case report. J Med Case Rep (2011) 0.84
Retinoblastoma: expression of HLA-G. Ocul Immunol Inflamm (2006) 0.81
Toxic optic neuropathy: an unusual cause. Indian J Ophthalmol (2014) 0.75
QUANTITATIVE ANALYSIS OF THE INNER RETINAL LAYER THICKNESSES IN AGE-RELATED MACULAR DEGENERATION USING CORRECTED OPTICAL COHERENCE TOMOGRAPHY SEGMENTATION. Retina (2017) 0.75
Reply. Retina (2017) 0.75
LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Retina (2017) 0.75
HIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina (2017) 0.75